• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Simultaneous targeting of DNA replication and homologous recombination in glioblastoma with a polyether ionophore

    Thumbnail
    View/Open
    Khanna253923Published.pdf (1.067Mb)
    Author(s)
    Lim, Yi Chieh
    Ensbey, Kathleen S
    Offenhauser, Carolin
    D'souza, Rochelle CJ
    Cullen, Jason K
    Stringer, Brett W
    Quek, Hazel
    Bruce, Zara C
    Kijas, Amanda
    Cianfanelli, Valentina
    Mahboubi, Bijan
    Smith, Fiona
    Jeffree, Rosalind L
    Wiesmueeller, Lisa
    Wiegmans, Adrian P
    Bain, Amanda
    Lombard, Fanny J
    Roberts, Tara L
    Khanna, Kum Kum
    Lavin, Martin F
    Kim, Baek
    Hamerlik, Petra
    Johns, Terrance G
    Coster, Mark J
    Boyd, Andrew W
    Day, Bryan W
    Griffith University Author(s)
    Coster, Mark J.
    Khanna, Kum K.
    Lombard, Fanny
    Year published
    2020
    Metadata
    Show full item record
    Abstract
    Background: Despite significant endeavor having been applied to identify effective therapies to treat glioblastoma (GBM), survival outcomes remain intractable. The greatest nonsurgical benefit arises from radiotherapy, though tumors typically recur due to robust DNA repair. Patients could therefore benefit from therapies with the potential to prevent DNA repair and synergize with radiotherapy. In this work, we investigated the potential of salinomycin to enhance radiotherapy and further uncover novel dual functions of this ionophore to induce DNA damage and prevent repair. Methods: In vitro primary GBM models and ex vivo ...
    View more >
    Background: Despite significant endeavor having been applied to identify effective therapies to treat glioblastoma (GBM), survival outcomes remain intractable. The greatest nonsurgical benefit arises from radiotherapy, though tumors typically recur due to robust DNA repair. Patients could therefore benefit from therapies with the potential to prevent DNA repair and synergize with radiotherapy. In this work, we investigated the potential of salinomycin to enhance radiotherapy and further uncover novel dual functions of this ionophore to induce DNA damage and prevent repair. Methods: In vitro primary GBM models and ex vivo GBM patient explants were used to determine the mechanism of action of salinomycin by immunoblot, flow cytometry, immunofluorescence, immunohistochemistry, and mass spectrometry. In vivo efficacy studies were performed using orthotopic GBM animal xenograft models. Salinomycin derivatives were synthesized to increase drug efficacy and explore structure-activity relationships. Results: Here we report novel dual functions of salinomycin. Salinomycin induces toxic DNA lesions and prevents subsequent recovery by targeting homologous recombination (HR) repair. Salinomycin appears to target the more radioresistant GBM stem cell-like population and synergizes with radiotherapy to significantly delay tumor formation in vivo. We further developed salinomycin derivatives which display greater efficacy in vivo while retaining the same beneficial mechanisms of action. Conclusion: Our findings highlight the potential of salinomycin to induce DNA lesions and inhibit HR to greatly enhance the effect of radiotherapy. Importantly, first-generation salinomycin derivatives display greater efficacy and may pave the way for clinical testing of these agents.
    View less >
    Journal Title
    Neuro-Oncology
    Volume
    22
    Issue
    2
    DOI
    https://doi.org/10.1093/neuonc/noz159
    Copyright Statement
    © The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
    Subject
    Neurosciences
    Oncology and Carcinogenesis
    Science & Technology
    Life Sciences & Biomedicine
    Oncology
    Clinical Neurology
    Neurosciences & Neurology
    Publication URI
    http://hdl.handle.net/10072/397341
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander